Contact Us
Physician Portal
Provides Taiwan eye care professionals with a well-established product to support healing in corneal-involved dry eye, keratitis, recurrent corneal erosions, and other ocular surface diseases Miami, FL – August 5, 2020 — Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, […]
Press Releases
Virtual symposium showcases results from study follow-up in which 86.2% of patients achieved complete closure of Wagner Grade 3-4 Diabetic Foot Ulcers (DFUs) with TTAX01 Cryopreserved Umbilical Cord allograft. Miami, FL – July 27, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, […]
Company’s first biologic license application (BLA) candidate TTAX01 to enter Investigational New Drug (IND) Phase 3 Trials for Diabetic Foot Ulcer (DFU) indication as first biologic product to seek FDA approval for complex Wagner Grade 3 and 4 DFUs Miami, FL – June 30, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and […]
86.2% of patients achieved complete closure with use of TTAX01 in the follow-up study, up from 50% confirmed closure during the original 16-week trial. Miami, FL – June 1, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from […]
Cryopreserved umbilical cord allograft is a novel treatment option due to its unique properties promoting a regenerative wound healing environment Miami, FL – May 18, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a prospective, single-center, […]
Inaugural day to bring awareness to Mechanical Dry Eye, one of the most overlooked and often misdiagnosed age-related eye conditions Miami, FL – May 4, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of human birth tissue products for ocular surface disease and disorders, has announced that the first-ever […]
Live webinars focus on Ophthalmic, Wound Care, Podiatry, and Orthopedic Indications using Cryopreserved Human Birth Tissue Miami, Fla. – April 21, 2020 – TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products and parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., announced today that they have rolled […]
RMAT designation reinforces clinical significance of investigational biologic product TTAX02 used during in-utero fetal surgical repair of spina bifida Miami, Fla. – April 16, 2020 – TissueTech, Inc., the pioneer in the development and clinical application of regenerative human birth tissue products, announced today that the U.S. Food and Drug Administration (FDA) has granted their […]
To bring awareness to Mechanical Dry Eye (MDE), one of the most overlooked and often misdiagnosed age-related eye conditions Miami, FL – April 10, 2020 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of cryopreserved amniotic membrane products for ocular surface disease and disorders, has announced the first-ever National Mechanical […]
Bio-Tissue, Inc. (Bio-Tissue), a TissueTech, Inc. company and pioneer and market leader in the ocular surface clinical application of human birth tissue-based products, announced today the availability of a collaborative publication designed to help clinicians optimize outcomes by improving the management of cornea-involved ocular surface diseases and the preparation of the ocular surface for refractive cataract surgery, all of which present continued unmet needs.
